Marketing-authorisation holder
RPH Pharmaceuticals AB
3 medicines in 2 countries, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Isosorbide Mononitraat Retard RPH 30 mg, tabletten met gereguleerde afgifteTablet met gereguleerde afgifte | Isosorbide mononitrate | Netherlands | Authorised | 2018 |
| Nystatine RPH 100.000 IE/ml, suspensie voor oraal gebruikSuspensie voor oraal gebruik | Nystatin | Netherlands | Authorised | 2017 |
| DEXMEDETOMIDINA RPH PHARMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG118 microgramos/ml · Concentrado para solución para perfusión | Dexmedetomidine | Spain | Withdrawn | 2024 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| Spain | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antidiarrhoeals and intestinal anti-infectivesAlimentary tract and metabolism · ATC A07A
- Cardiac therapyCardiovascular system · ATC C01D
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- rph
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 2
- Roles
- Authorisation holder and marketer